ArticleOPEN ACCESS

Is adagrasib just another sotorasib?—or, should we differentiate their usage according to patients’ clinical presentation?

Translational Lung Cancer Research
DOI: 10.21037/tlcr-23-97
11Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Author supplied keywords

Cite

CITATION STYLE

APA

Oya, & Mitsudomi, T. (2023, May 31). Is adagrasib just another sotorasib?—or, should we differentiate their usage according to patients’ clinical presentation? Translational Lung Cancer Research. AME Publishing Company. https://doi.org/10.21037/tlcr-23-97

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free